当前位置: X-MOL 学术Genet. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.
Genetics in Medicine ( IF 6.6 ) Pub Date : 2018-01-04 , DOI: 10.1038/gim.2017.210
Sean V Tavtigian 1 , Marc S Greenblatt 2 , Steven M Harrison 3 , Robert L Nussbaum 4 , Snehit A Prabhu 5 , Kenneth M Boucher 6 , Leslie G Biesecker 7 ,
Affiliation  

PURPOSE We evaluated the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) variant pathogenicity guidelines for internal consistency and compatibility with Bayesian statistical reasoning. METHODS The ACMG/AMP criteria were translated into a naive Bayesian classifier, assuming four levels of evidence and exponentially scaled odds of pathogenicity. We tested this framework with a range of prior probabilities and odds of pathogenicity. RESULTS We modeled the ACMG/AMP guidelines using biologically plausible assumptions. Most ACMG/AMP combining criteria were compatible. One ACMG/AMP likely pathogenic combination was mathematically equivalent to pathogenic and one ACMG/AMP pathogenic combination was actually likely pathogenic. We modeled combinations that include evidence for and against pathogenicity, showing that our approach scored some combinations as pathogenic or likely pathogenic that ACMG/AMP would designate as variant of uncertain significance (VUS). CONCLUSION By transforming the ACMG/AMP guidelines into a Bayesian framework, we provide a mathematical foundation for what was a qualitative heuristic. Only 2 of the 18 existing ACMG/AMP evidence combinations were mathematically inconsistent with the overall framework. Mixed combinations of pathogenic and benign evidence could yield a likely pathogenic, likely benign, or VUS result. This quantitative framework validates the approach adopted by the ACMG/AMP, provides opportunities to further refine evidence categories and combining rules, and supports efforts to automate components of variant pathogenicity assessments.

中文翻译:


将 ACMG/AMP 变体分类指南建模为贝叶斯分类框架。



目的 我们评估了美国医学遗传学和基因组学学院/分子病理学协会 (ACMG/AMP) 变异致病性指南的内部一致性以及与贝叶斯统计推理的兼容性。方法 ACMG/AMP 标准被转化为朴素贝叶斯分类器,假设四个级别的证据和指数缩放的致病性几率。我们用一系列先验概率和致病性几率测试了这个框架。结果我们使用生物学上合理的假设对 ACMG/AMP 指南进行了建模。大多数 ACMG/AMP 组合标准是兼容的。一种 ACMG/AMP 可能致病的组合在数学上等同于致病,而一种 ACMG/AMP 致病组合实际上可能致病。我们对包括支持和反对致病性的证据的组合进行了建模,表明我们的方法将一些组合评分为致病性或可能致病性,ACMG/AMP 将指定为不确定意义的变体 (VUS)。结论 通过将 ACMG/AMP 指南转化为贝叶斯框架,我们为定性启发法提供了数学基础。 18 个现有的 ACMG/AMP 证据组合中只有 2 个在数学上与整体框架不一致。致病性和良性证据的混合组合可能会产生可能致病性、可能良性或 VUS 结果。该定量框架验证了 ACMG/AMP 采用的方法,提供了进一步细化证据类别和组合规则的机会,并支持自动化变异致病性评估组件的努力。
更新日期:2018-01-05
down
wechat
bug